Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

Auteurs : Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, de Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A, Ferraresi V, Ferrari A, Fletcher CDM, Garcia Del Muro X, Gelderblom H, Gladdy RA, Gouin F, Grignani G, Gutkovich J, Haas R, Hindi N, Hohenberger P, Huang P, Joensuu H, Jones RL, Jungels C, Kasper B, Kawai A, Le Cesne A, Le Grange F, Leithner A, Leonard H, Lopez Pousa A, Martin Broto J, Merimsky O, Merriam P, Miceli R, Mir O, Molinari M, Montemurro M, Oldani G, Palmerini E, Pantaleo MA, Patel S, Piperno-Neumann S, Raut CP, Ravi V, Razak ARA, Reichardt P, Rubin BP, Rutkowski P, Safwat AA, Sangalli C, Sapisochin G, Sbaraglia M, Scheipl S, Schöffski P, Strauss D, Strauss SJ, Sundby Hall K, Tap WD, Trama A, Tweddle A, van der Graaf WTA, Van De Sande MAJ, van Houdt W, van Oortmerssen G, Wagner AJ, Wartenberg M, Wood J, Zaffaroni N, Zimmermann C, Casali PG, Dei Tos AP, Gronchi A
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100170

State of the art and future directions in the systemic treatment of neuroendocrine neoplasms.

Auteurs : Jungels C, Deleporte A
Jaar : 2021
Journal : Curr Opin Oncol

Editorial: Endocrine tumors, rare tumors.

Auteurs : Jungels C
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 1-2

Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.

Auteurs : Benkhaled S, Mané M, Jungels C, Shumelinsky F, de Saint-Aubain de Somerhausen N, Van Gestel D
Jaar : 2021
Journal : Cancer Treat Res Commun
Volume : 26
Pagina's : 100282

Safety, anti-tumor activity and T-cell responses in a dose-ranging phase 1 trial of the oncolytic peptide LTX-315 in patients with solid tumors.

Auteurs : Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø
Jaar : 2021
Journal : Clin Cancer Res

131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma.

Auteurs : Jungels C, Karfis I
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 33-39

Endocrine tumors, rare tumors.

Auteurs : Jungels C
Jaar : 2020
Journal : Curr Opin Oncol

A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.

Auteurs : Le Tourneau C, Delord JP, Kotecki N, Borcoman E, Gomez-Roca C, Hescot S, Jungels C, Vincent-Salomon A, Cockenpot V, Eberst L, Molé A, Jdey W, Bono F, Trochon-Joseph V, Toussaint H, Zandanel C, Adamiec O, de Beaumont O, Cassier PA
Jaar : 2020
Journal : Br J Cancer
Volume : 123
Pagina's : 1481-1489